elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37789693-5955DB0F-E691-4200-9695-5A30DBA853BD
Q37789693-5955DB0F-E691-4200-9695-5A30DBA853BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37789693-5955DB0F-E691-4200-9695-5A30DBA853BD
Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease.
P31
Q37789693-5955DB0F-E691-4200-9695-5A30DBA853BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37789693-5955DB0F-E691-4200-9695-5A30DBA853BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ae223e20d57714b0d6db9d0d52b5088a43bff98
P31
scholarly article